Radyx Pharma Tech ApS is a Danish APS based in Beder, operating in the Computer consultancy and computer facilities management activities sector. Incorporated in 2025, the company reported a gross profit of -DKK 4.7k in its latest annual filing.
EBITDA margin (of gross profit) 100.0 %
Solidity ratio Equity ÷ Total assets × 100 Among the 10% highest rated companies in the industry
2025 2025
Liquidity ratio Current assets ÷ Short-term debt 2025 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 40% lowest rated companies in the industry
2025 2025
0 -1455 -2910 -4364 -5819 2025: -4673 -4673 2025
Key figures Annual report 2025 Gross profit -4.7K DKK — EBITDA -4.7K DKK — Net profit -5.7K DKK — Total assets 94.3K DKK — Equity 94.3K DKK — Employees — —
Legal name
Radyx Pharma Tech ApS
Founded
16 July 2025 · 1 year
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med bestyrelsens formand, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er udvikling og salg af software til medicinalindustrien.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), Radyx Pharma Tech ApS reported a gross profit of -DKK 4.7k. The bottom line showed a net loss of DKK 5.7k.
At the end of 2025, equity financed 100% of the balance sheet.
Frequently asked questions What is the CVR number of Radyx Pharma Tech ApS? Radyx Pharma Tech ApS is registered with CVR / Virk under CVR 45756726.
What is the gross profit of Radyx Pharma Tech ApS? Radyx Pharma Tech ApS reported a gross profit of -DKK 4.7k in 2025.
Who is the chairman of Radyx Pharma Tech ApS? Thomas Bak chairs the board of Radyx Pharma Tech ApS.
Where is Radyx Pharma Tech ApS headquartered? Radyx Pharma Tech ApS's registered address is Fuldenvej 71.
More on Radyx Pharma Tech ApS 